Menu
×
×

Sign Up

Your Profile will be reviewed by Admin
EVENT DATE
Jun 2014
MoTuWeThFrSaSu
      1
2345678
9101112131415
16171819202122
23242526272829
30      

Venue

Doubletree by Hilton 181 Church St Charleston , South Carolina 29401
Tel: (843) 577-2644
Website
Google Map

18th Annual Hypertension, Diabetes And Dyslipidemia Conference (endorsed By The American Society Of Hypertension)

Overview

18th Annual Hypertension, Diabetes and Dyslipidemia Conference

http://cmemeeting.com/18th-annual-hypertension-conference-2014

OVERVIEW

In collaboration with the Carolinas, Georgia, Florida Chapter of the American Society of Hypertension, we are pleased to offer the 18th Annual Conference on Hypertension, Diabetes and Dyslipidemia.  This three day intensive conference will be held on June 27-29, 2014 at the DoubleTree by Hilton Hotel & Suites Charleston - Historic District in downtown Charleston, South Carolina and has been endorsed by the American Society of Hypertension.

Explore the past in Charleston, South Carolina and enjoy the present at one of the top hotels in Charleston, SC at the DoubleTree by Hilton Hotel & Suites Charleston - Historic District. Located on the corner of Church and Market streets, the full-service hotel opens to Charleston’s City Market in the Historic District. This hotel is truly located in the heart of this beautiful city!   Charleston was recently voted the #1 city in the US by Travel & Leisure and this conference is a great opportunity for you to see why!
Physicians attending the conference may chose to lengthen their stay by attending the 22st Annual Primary Care Conference which will take place June 30-July 4 at nearby Kiawah Island Resort.  Kiawah and its beautiful beaches are just a 40 minutes drive away.  Special combination pricing is available as well as one day pricing.

PROGRAM DESCRIPTION  

Gaps in the level of Hemoglobin A1C, BP, and LDL-Cholesterol reduction continue to occur in high-risk individuals with Type 2 diabetes, Hypertension, and Dyslipidemia, respectively. Recent results from the ACCORD, VADT, and ADVANCE studies suggest the benefits on reducing macrovascular disease events are unclear and, in fact, caution should be exercised when reducing Hemoglobin A1C in those with long standing Type 2 diabetes to a goal of < 6% when compared to a goal between 7 and 7.9%. In addition, controversy continues from recent guidelines on the level of LDL-cholesterol and BP reduction that can be and should be achieved. This conference will address these and other issues confronting the clinician who treats patients with diabetes, hypertension, and dyslipidemia.  The participant will learn the most current information on these issues and will be able to transport these clinical principles back to their every day practice to improve patient care.

OBJECTIVES At the completion of this activity, participants should be better prepared to:

• Discuss goals, medications and controversies surrounding management of patients with Diabetes, Hypertension and Dyslipidemia;

• Describe appropriate treatment plans for these individuals; and

• Apply new learning to improve health outcomes involving patients with Diabetes, Hypertension, and Dyslipidemia.

Notes:
Sponsorship Details:

RELATED EVENTS +

MORE events +

Display Makers +

Promo Makers +

Other Services Providers